NIEMAN LAB – 11/02/2019
Ken Doctor
Alden’s offer to buy Gannett looks less and less credible. But can Tribune and Gannett suss out the merger that might be necessary to stop it?
NIEMAN LAB – 11/02/2019
Ken Doctor
Alden’s offer to buy Gannett looks less and less credible. But can Tribune and Gannett suss out the merger that might be necessary to stop it?